# Braveheart Bio, Inc. (BRVE): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Braveheart Bio, Inc. (BRVE) is 17/100, ranked against 24,000+ stocks in 35 markets (Quality 38, Value 25, Momentum 34, each scored against its sector).

- StockRank: 17/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 38, Value 25, Momentum 34: each a 0-100 percentile within Healthcare.
- Position: #21,864 overall, #2,006 in Healthcare.
- Listing: United States, NGM; Healthcare / Biotechnology.
- Last close: 21.87 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 38.0M; 5%+ holders bought USD 84.6M.

Source: https://moatmap.ai/stock/BRVE
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker